Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children.

Heyes MP, Saito K, Milstien S, Schiff SJ.

J Neurol Sci. 1995 Nov;133(1-2):112-8.

PMID:
8583213
2.
3.

Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.

Yoshioka M, Bradley WG, Shapshak P, Nagano I, Stewart RV, Xin KQ, Srivastava AK, Nakamura S.

Adv Neuroimmunol. 1995;5(3):335-58. Review.

PMID:
8748077
4.

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.

Muller N, Schwarz M.

Neurotox Res. 2006 Oct;10(2):131-48. Review.

PMID:
17062375
5.

Neopterin production, tryptophan degradation, and mental depression--what is the link?

Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D.

Brain Behav Immun. 2002 Oct;16(5):590-5. Review.

PMID:
12401473
6.

The kynurenine pathway and neurologic disease. Therapeutic strategies.

Heyes MP.

Adv Exp Med Biol. 1996;398:125-9. Review.

PMID:
8906254
7.

Neurosonographic features of central nervous system infections in infancy and childhood.

Frank LM, White LE.

J Child Neurol. 1989;4 Suppl:S41-51. Review.

PMID:
2681377
8.

Biomarkers of inflammatory and auto-immune central nervous system disorders.

Dale RC, Brilot F.

Curr Opin Pediatr. 2010 Dec;22(6):718-25. doi: 10.1097/MOP.0b013e3283402b71. Review.

PMID:
20871402
9.

Quinolinic acid and other kynurenines in the central nervous system.

Stone TW, Connick JH.

Neuroscience. 1985 Jul;15(3):597-617. Review. No abstract available.

PMID:
2866466
10.

Extrinsic factors that put patients at risk of acquiring central nervous system infections.

Robinson EN Jr, Woods ML, McGee ZA.

Am J Med. 1984 May 15;76(5A):208-14. Review.

PMID:
6372472
11.

Quinolinic acid: an endogenous neurotoxin with multiple targets.

Lugo-Huitrón R, Ugalde Muñiz P, Pineda B, Pedraza-Chaverrí J, Ríos C, Pérez-de la Cruz V.

Oxid Med Cell Longev. 2013;2013:104024. doi: 10.1155/2013/104024. Epub 2013 Sep 5. Review.

12.

Clinico-pathological and pathogenetic aspects of CNS HIV infection in children.

Dal Canto MC.

Minerva Pediatr. 1992 Oct;44(10 Suppl 1):155-72. Review. No abstract available.

PMID:
1470068
13.

Neurologic complications of cytokine therapy.

Forman AD.

Oncology (Williston Park). 1994 Apr;8(4):105-10; discussion 113, 116-7. Review.

PMID:
8003395
14.

The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders.

Kandanearatchi A, Brew BJ.

FEBS J. 2012 Apr;279(8):1366-74. doi: 10.1111/j.1742-4658.2012.08500.x. Epub 2012 Mar 27. Review.

15.

Quinolinic acid and inflammation.

Heyes MP.

Ann N Y Acad Sci. 1993 May 28;679:211-6. Review. No abstract available.

PMID:
8512184
16.

Immunology of major depression.

Müller N.

Neuroimmunomodulation. 2014;21(2-3):123-30. doi: 10.1159/000356540. Epub 2014 Feb 14. Review.

PMID:
24557045
17.

Nonanthrax Bacillus infections of the central nervous system.

Weisse ME, Bass JW, Jarrett RV, Vincent JM.

Pediatr Infect Dis J. 1991 Mar;10(3):243-6. Review. No abstract available.

PMID:
1904148
18.

Clinical neurologic disorders in children with special otorhinolaryngologic relationships.

Mackey RW.

Otolaryngol Clin North Am. 1987 Feb;20(1):13-34. Review.

PMID:
3550590
19.

[Transillumination, hydrocephalometry and encephalovolumopulsography in studies of the central nervous system in children].

Emeryk A, Tuszewski T.

Wiad Lek. 1984 Jun 1;37(11):853-6. Review. Polish. No abstract available.

PMID:
6390981
20.

Cytokines and tumors of the central nervous system.

Van Meir EG.

Glia. 1995 Nov;15(3):264-88. Review.

PMID:
8586463

Supplemental Content

Support Center